A carregar...

A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma

Temozolomide is an alkylating agent with activity in the treatment of melanoma metastatic to the brain. Lomustine is a nitrosurea that crosses the blood brain barrier and there is evidence to suggest that temozolomide may reverse resistance to lomustine. A multicentre phase I/II study was conducted...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Larkin, J M G, Hughes, S A, Beirne, D A, Patel, P M, Gibbens, I M, Bate, S C, Thomas, K, Eisen, T G, Gore, M E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360201/
https://ncbi.nlm.nih.gov/pubmed/17146474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!